| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
23,789,000 |
| Market
Cap: |
713.67(K) |
| Last
Volume: |
1,497,358 |
Avg
Vol: |
1,493,199 |
| 52
Week Range: |
$0.03 - $0.03 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ImmunoCellular Therapeutics is a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of cancers. Co.'s clinical product candidates include: ICT-107, which is a dendritic cell (DC) immunotherapy for the treatment of newly diagnosed glioblastoma multiforme, a lethal type of brain cancer; ICT-140, which is a DC immunotherapy that targets seven tumor-associated antigens expressed on ovarian cancer cells; and ICT-121, which specifically targets CD133, a cancer stem cell marker that is in a variety of solid tumors, including ovarian, pancreatic, and breast cancers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Yu John S |
Director |
– • – |
2018-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
120,250 |
|
- |
|
| Fractor David |
VP of Finance |
• – – |
2016-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
70,000 |
|
- |
|
| Swanson Steven J |
Senior Vice President, Researc |
• – – |
2016-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
| Gengos Andrew |
President and CEO |
• • – |
2016-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
341,333 |
|
- |
|
| Gringeri Anthony |
Senior VP Strategic Resources |
• – – |
2016-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
150,000 |
|
- |
|
| Gengos Andrew |
President and CEO |
• • – |
2015-11-30 |
4 |
B |
$0.44 |
$4,350 |
I/I |
10,000 |
47,000 |
2.58 |
- |
|
| Yu John S |
Director |
– • – |
2015-09-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,326 |
10,326 |
|
- |
|
| Yu John S |
Director |
– • – |
2015-09-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,326 |
10,000 |
|
- |
|
| Yu John S |
Director |
– • – |
2015-09-28 |
4 |
D |
$0.46 |
$6,750 |
D/D |
(14,674) |
20,326 |
|
- |
|
| Yu John S |
Director |
– • – |
2015-09-28 |
4 |
OE |
$0.27 |
$6,750 |
D/D |
25,000 |
35,000 |
|
- |
|
| Titus Gary |
Director |
– • – |
2015-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
28,000 |
|
- |
|
| Singhvi Rahul |
Director |
– • – |
2015-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
15,000 |
|
- |
|
| Fractor David |
See Remarks |
• – – |
2015-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
35,000 |
|
- |
|
| Gengos Andrew |
President and CEO |
• • – |
2015-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
228,333 |
|
- |
|
| Gringeri Anthony |
Sr. VP, Strategic Resources |
• – – |
2015-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
75,000 |
|
- |
|
| Fractor David |
VP of Finance |
• – – |
2015-02-18 |
4 |
B |
$0.60 |
$10,000 |
D/D |
16,667 |
41,667 |
2.74 |
- |
|
| Gengos Andrew |
President and CEO |
• • – |
2015-02-18 |
4 |
B |
$0.60 |
$24,800 |
D/D |
41,333 |
78,333 |
2.81 |
- |
|
| Gringeri Anthony |
Senior VP Strategic Resources |
• – – |
2015-02-18 |
4 |
B |
$0.60 |
$18,000 |
D/D |
30,000 |
66,000 |
2.74 |
- |
|
| Gringeri Anthony |
Senior VP Strategic Resources |
• – – |
2014-08-21 |
4 |
B |
$0.91 |
$10,010 |
I/I |
11,000 |
36,000 |
1.99 |
- |
|
| Gengos Andrew |
President and CEO |
• • – |
2014-08-14 |
4 |
B |
$0.90 |
$8,994 |
D/D |
10,000 |
37,000 |
2.81 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
|
